Compare
Vtex vs Definitive Healthcare Corp. vs PLAYSTUDIOS, Inc. vs Cerence Inc.
| Latest fiscal year | Vtex VTEX | Definitive Healthcare Corp. DH | PLAYSTUDIOS, Inc. MYPS | Cerence Inc. CRNC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $240.52M | $241.52M | $235.10M | $251.78M |
| Revenue growth (YoY) | +6.1% | -4.2% | -18.8% | -24.0% |
| Gross margin | 77.5% | 75.9% | n/a | 72.7% |
| Operating margin | 7.5% | -92.9% | -10.2% | -0.9% |
| Net margin | 8.3% | -57.5% | -12.2% | -7.4% |
| Net income | $20.01M | -$138.93M | -$28.64M | -$18.71M |
| EPS (Diluted) | $0.11 | -$1.30 | -$0.23 | -$0.43 |
| Operating cash flow | $33.37M | $53.78M | $26.34M | $61.17M |
| Free cash flow | $32.33M | $37.06M | $25.37M | $46.82M |
| Cash & equivalents | $15.74M | $163.63M | $104.94M | n/a |
| Total assets | $346.63M | $735.49M | $290.62M | $630.59M |
| Total liabilities | n/a | $356.50M | $62.75M | $479.92M |
| Shareholders' equity | $233.56M | $378.99M | $227.87M | $150.68M |
| Return on year-end equity | 8.6% | -36.7% | -12.6% | -12.4% |
| Shares outstanding | n/a | n/a | n/a | 43.37M |
Revenue, most recent five fiscal years
| Fiscal year | Vtex | Definitive Healthcare Corp. | PLAYSTUDIOS, Inc. | Cerence Inc. |
|---|---|---|---|---|
| Latest | $240.52M Ended 2025-12-31 | $241.52M Ended 2025-12-31 | $235.10M Ended 2025-12-31 | $251.78M Ended 2025-09-30 |
| 1 year earlier | $226.66M Ended 2024-12-31 | $252.20M Ended 2024-12-31 | $289.43M Ended 2024-12-31 | $331.50M Ended 2024-09-30 |
| 2 years earlier | $200.83M Ended 2023-12-31 | $251.41M Ended 2023-12-31 | $310.89M Ended 2023-12-31 | $294.48M Ended 2023-09-30 |
| 3 years earlier | n/a | $222.65M Ended 2022-12-31 | $290.31M Ended 2022-12-31 | $327.89M Ended 2022-09-30 |
| 4 years earlier | n/a | $166.15M Ended 2021-12-31 | $287.42M Ended 2021-12-31 | $387.18M Ended 2021-09-30 |